← SynDRA
GSK-3008348 FREE BASE
SynDRA canonical compound SYN0039345 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ITGAV | ITGB6 |
|---|
| Mechanism of action | integrin antagonist |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Gsk3008348 free base
- integrin-antagonist-1
- L6EE7H64YF
- orb1703409
- SCHEMBL16140801
- GTPL12736
- BDBM50464108
- AKOS040745826
- NCGC00522445-02
- AC-36830
- T24108
- BRD-K88165431-003-01-4
- (3S)-3-[3-(3,5-dimethylpyrazol-1-yl)phenyl]-4-[(3R)-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]pyrrolidin-1-yl]butanoic acid
- GSK3008348E
- GSK-3008348 hydrochloride
- GLXC-10124
- Gsk-3008348
- AC-38425
- FG183203
- Gsk3008348
- GSK3008348 monohydrochloride
- T15583
- RefChem:922536
- Gsk3008348e
- SCHEMBL18092914
- GSK3008348
- orb1707179
- Gsk3008348 monohydrochloride
- RGD-mimetic-1
- SCHEMBL30649096
Look up GSK-3008348 FREE BASE in the interactive SynDRA portal →